
Lingyi Bio
凌意生物
Lingyi Bio
Biotech/Healthcare
Founded in February 2021, Lingyi Biotech is a gene-therapy company with a globally leading functional-validation platform based on animal models of rare diseases. It is committed to source innovation and focuses on inherited rare diseases in areas including metabolism, the central nervous system…
Latest round: Series B Extension (2025)
Source: ChinaBulls — chinabulls.com
Last updated 2025-12-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.